Feed Insights Top Reports Pricing

⌘K

16:07:38·10d

SECFilingvia Quantisnow

SEC Form DEFA14A filed by Duolingo Inc.

ByQuantisnow·Wall Street's wire, on your screen.

DUOL· Duolingo Inc.

Technology

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DUOL (Duolingo Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

DUOL
Duolingo Inc.
Technology

Recent analyst ratings

Mar 18UpdateArgus-
Feb 27UpdateTruist$100.00
Feb 27UpdateBofA Securities$100.00
Feb 27UpdateScotiabank$100.00
Feb 27UpdateAnalyst$95.00
Feb 27UpdateEvercore ISI$114.00

Related

SEC10d
SEC Form DEF 14A filed by Duolingo Inc.
PR21d
Duolingo to Announce First Quarter 2026 Results on Monday, May 4, 2026
INSIDER31d
SEC Form 4 filed by Munson Gillian
SEC32d
Amendment: SEC Form SCHEDULE 13G/A filed by Duolingo Inc.
ANALYST40d
Duolingo downgraded by Argus
INSIDER42d
Chief Business Officer Meese Robert exercised 30,000 shares at a strike of $19.17, increasing direct ownership by 24% to 152,636 units (SEC Form 4)
INSIDER54d
Director Shelton James H bought $498,792 worth of shares (5,000 units at $99.76), increasing direct ownership by 108% to 9,632 units (SEC Form 4)
INSIDER55d
Chief Engineering Officer Glance Natalie exercised 24,252 shares at a strike of $6.08, increasing direct ownership by 21% to 139,632 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022